EB

BPGbio Wins 2023 BioTech Breakthrough Award for Therapeutics Platform of The Year

Retrieved on: 
Wednesday, November 8, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231108370629/en/
    BPGbio named Therapeutics Platform of the Year by Biotech Breakthrough Awards program.
  • The award recognizes BPGbio’s success leveraging their NAi Interrogative Biology Platform to develop late-stage therapeutics and diagnostics for some of the most challenging diseases.
  • “We are honored that BPGbio has won the Therapeutics Platform of the Year from BioTech Breakthrough, a massive achievement for our employees and research partners.
  • BPGbio, our ‘Therapeutics Platform of the Year’ winner, is proving the value of AI in drug discovery for the future of medicine,” said Bryan Vaughn, Managing Director of BioTech Breakthrough Awards.

BPGbio Highlights AI-Developed Late-Stage Therapeutics Assets at 8th Annual INV€$TIVAL Showcase in Partnership with Jefferies

Retrieved on: 
Tuesday, November 7, 2023

BPGbio will present as part of the event’s Biotech Late Growth Stage track.

Key Points: 
  • BPGbio will present as part of the event’s Biotech Late Growth Stage track.
  • Last month, an independent medical advisory board recommended advancement into phase 2b trials for pancreatic cancer.
  • BPM31510 for pancreatic cancer has received orphan drug designation from the U.S. Food and Drug Administration.
  • This platform identifies targets, biomarkers, and drugs and assists the development team through both the developmental and clinical trial stages.

Nokia Technology Strategy 2030: emerging technology trends and their impact on networks

Retrieved on: 
Tuesday, October 31, 2023

Nokia’s Technology Strategy 2030 is fundamental to realizing the full potential of AI, cloud and other emerging trends with connectivity at the center enabling the adoption of these technologies

Key Points: 
  • Nokia’s Technology Strategy 2030 is fundamental to realizing the full potential of AI, cloud and other emerging trends with connectivity at the center enabling the adoption of these technologies
    Espoo, Finland – Nokia today presents its Technology Strategy 2030 that identifies trends and emerging technologies that will shape technology, networks and the world for the next seven years.
  • Nishant Batra, Chief Strategy and Technology Officer, Nokia, said: “Nokia’s Technology Strategy 2030 is a direct response to the proliferation of cutting-edge technologies over the last decade.
  • The key trends influencing Nokia’s Technology Strategy 2030 are AI, cloud continuum, metaverse, API economy, Industry 5.0, Internet of value, sustainability, and security.
  • Nokia, and the industry as a whole, must show that they understand the problems and potential, with a revitalized approach as indicated by the long-term Nokia Technology Strategy 2030.”

Eventbrite Reports Third Quarter 2023 Financial Results

Retrieved on: 
Wednesday, November 1, 2023

Eventbrite, Inc. (NYSE:EB), a global events marketplace, today posted its financial results for the third quarter ended September 30, 2023.

Key Points: 
  • Eventbrite, Inc. (NYSE:EB), a global events marketplace, today posted its financial results for the third quarter ended September 30, 2023.
  • The Third Quarter Shareholder Letter can be found on Eventbrite’s Investor Relations website at https://investor.eventbrite.com .
  • “We’re proud of our strong execution in the third quarter as we achieved record take rate and revenue per ticket.
  • The webcast of the conference call can be accessed as follows:
    An archived webcast of the conference call will also be accessible on Eventbrite’s Investor Relations page, https://investor.eventbrite.com .

A New Hope for Epidermolysis Bullosa (“butterfly children”) Thanks to Novel CRISPR-Cas3 Platform

Retrieved on: 
Monday, October 30, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231030362422/en/
    Epidermolysis bullosa is a rare genetic skin disorder characterized by highly sensitive skin that blisters and erodes with minimal friction or trauma, such as rubbing or scratching.
  • EB affects approximately 20 out of every 1 million newborns in the United States where 25,000 to 50,000 young children are living with this debilitating condition.
  • The collaborative endeavor between Healiva and C4U will focus on the development of CRISPR-Cas3 based gene therapy for EB.
  • “By utilizing its proprietary CRISPR-Cas3 technology, a new generation of gene editing technology, C4U’s focus is to develop alternative and complete cures to genetic diseases.

Onconova Expands Leadership Team with Two Key Appointments

Retrieved on: 
Tuesday, October 24, 2023

NEWTOWN, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”, the “Company”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that the Company expanded its leadership team with the naming of Dr. Victor Moyo as Chief Medical Officer (CMO), and the addition of Meena Arora as Vice President, Global Medical Affairs and Research and Development (R&D).

Key Points: 
  • Both are accomplished experts in their fields and bring significant and wide expertise in drug development.
  • I look forward to working with my colleagues at Onconova and our clinical collaborators to contribute to our mission of bringing narazaciclib and rigosertib to patients with cancer.
  • He has also held various leadership roles as Vice President of Clinical Investigations at Merrimack Pharmaceuticals and the Centocor Ortho Biotech Services, LLC division of Johnson & Johnson.
  • Prior to that, she held various leadership roles as Medical Director or Associate Medical Director, as well as roles in Investigator Research and Medical Affairs at Celgene International.

NJOY Brings Sweeping Litigation Against Illicit Disposable Vapor Manufacturers

Retrieved on: 
Thursday, October 19, 2023

Altria Group, Inc. (Altria) announces today its operating company NJOY, LLC (NJOY) has filed sweeping litigation against 34 foreign and domestic manufacturers, distributors and online retailers of illicit disposable e-vapor products that are unlawfully marketed and sold in the State of California and elsewhere.

Key Points: 
  • Altria Group, Inc. (Altria) announces today its operating company NJOY, LLC (NJOY) has filed sweeping litigation against 34 foreign and domestic manufacturers, distributors and online retailers of illicit disposable e-vapor products that are unlawfully marketed and sold in the State of California and elsewhere.
  • The suit seeks a nation-wide injunction against the import, marketing and sale of these illicit products and significant compensatory and punitive damages.
  • “Today there are two markets – one for those who play by the rules and one for those who flagrantly ignore them.
  • NJOY may add additional manufacturers, distributors and retailers to this complaint and will consider further litigation activity.

Eventbrite Announces Date of Third Quarter 2023 Financial Results

Retrieved on: 
Wednesday, October 18, 2023

Eventbrite, Inc. (NYSE: EB), a global events marketplace, announced that it will release its financial results for the third quarter ended September 30, 2023, after the market closes on Wednesday, November 1, 2023.

Key Points: 
  • Eventbrite, Inc. (NYSE: EB), a global events marketplace, announced that it will release its financial results for the third quarter ended September 30, 2023, after the market closes on Wednesday, November 1, 2023.
  • An archived webcast of the conference call will be accessible on Eventbrite’s Investor Relations page, https://investor.eventbrite.com .

Everything Blockchain, Inc. Named Winner in 2023 CyberSecurity Breakthrough Awards

Retrieved on: 
Thursday, October 5, 2023

All entries were judged based on performance, ease of use and manageability and functionality.

Key Points: 
  • All entries were judged based on performance, ease of use and manageability and functionality.
  • From thousands of nominations, EBI was selected alongside major industry players including CrowdStrike, Proofpoint, Fortinet, HUMAN Security, and VMWare.
  • EB Control delivers zero-trust data protection to small and mid-size businesses without the cost or expertise typically required to manage it.
  • “We’re thrilled to be named a winner in the 2023 CyberSecurity Breakthrough Awards,” said Toney Jennings, CEO of EBI.

Claure Group Acquires Significant Stake in eB Capital, One of the Leading Alternative Investment Firms in Brazil

Retrieved on: 
Wednesday, October 11, 2023

eB Capital, a leading Brazilian investment firm founded by Eduardo Sirotsky Melzer, Luciana Antonini Ribeiro and Pedro Parente, announces that Claure Group has acquired a significant stake in the firm.

Key Points: 
  • eB Capital, a leading Brazilian investment firm founded by Eduardo Sirotsky Melzer, Luciana Antonini Ribeiro and Pedro Parente, announces that Claure Group has acquired a significant stake in the firm.
  • Following the investment, Marcelo Claure will join the firm as Vice Chairman and Managing Partner, and a member of the investment committee.
  • Mr. Claure is a preeminent investor, operator and entrepreneur, and the founder and CEO of Claure Group, a global investment firm with approximately USD $4 billion under management in various sectors.
  • Mr. Claure will leverage his entrepreneurial expertise and his experience leading global companies as part of the investment in eB Capital, with the objective to further eB Capital’s growth strategy.